Stonepine Capital Management’s TELA Bio TELA Stock Holding History
Bought
Maintained
Sold
Other funds holding TELA
EWM
NCM
SCM
DCM
PCM
SCM
WA
Stonepine Capital Management's TELA Position: Q2 2026 in Review
Stonepine Capital Management increased its TELA Bio (TELA) stake by 1.7% in Q2 2026, buying an estimated $37K and bringing the position to 2,662,427 shares worth $2M. The position accounts for 1.13% of the portfolio, ranked #28.
Stonepine Capital Management first reported a position in TELA in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.11M in Q4 2024. 45 funds tracked by Wall St. Rank hold TELA as of Q2 2026.
- Stonepine Capital Management held 2,662,427 shares of TELA Bio worth $2M as of Q2 2026.
- Stonepine Capital Management bought 45,175 TELA Bio shares in Q2 2026, an estimated $37K.
- TELA Bio made up 1.13% of Stonepine Capital Management's portfolio in Q2 2026, its #28 holding.
- Stonepine Capital Management first reported a position in TELA Bio in Q2 2023 and has held it in 13 quarters since.
- Stonepine Capital Management's TELA Bio position peaked at $7.11M in Q4 2024.
- 45 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.
Based on Stonepine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.